Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
HWH vs COCH: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
COCH Wins Head-to-Head Institutional Verdict (2–2 across 6 Pillars · 4–3 Matrix Metrics)
COCH Overall Winner
6-Pillar Tally: HWH 2 – 2 COCH (2 Tie)
Matrix Metrics: HWH 3 – 4 COCH
As of Nov 20, 2026, Envoy Medical, Inc. (COCH) is the stronger overall head-to-head candidate over HWH International Inc. (HWH) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow). HWH carries a Unified Composite Score of 37.4/100 (SELL) at $2.68 (N/M Forward P/E, -356.2% operating margin), whereas COCH carries 35.1/100 (SELL) at $6.70 (N/M Forward P/E, -10261.0% operating margin).
- Composite vs. Pillar Nuance: While HWH currently prints a higher short-term Unified Composite Score (37.4/100 SELL vs. COCH 35.1/100 SELL), COCH captures the overall institutional head-to-head verdict (4–3 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (-10261.0% vs. -356.2% operating margin) and revenue trajectory (+57.1% vs. -79.3% YoY).
- Defensive Composite Rating Caution: Although COCH compares more favorably head-to-head, both HWH (37.4/100 SELL) and COCH (35.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HWH vs COCH
HWH
HWH International Inc. Common Stock
$2.68
+15.02% 1D
Market Cap
$18.0M
TTM Revenue
$389,738
Forward P/E
N/M
Beta / 30D Vol
1.02β · 88% Vol
Unified Composite Score
37.4
SELL
Tech 15.0
Fund 34.0
Flow 50.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
COCH
Head-to-Head Winner
Envoy Medical, Inc. Class A Common Stock
$6.70
+0.0% 1D
Market Cap
$51.9M
TTM Revenue
$231,000
Forward P/E
N/M
Beta / 30D Vol
4.94β · 3352% Vol
Unified Composite Score
35.1
SELL
Tech 50.0
Fund 27.0
Flow 50.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (HWH 2 – 2 COCH)
1. Valuation Multiples
HWH
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
42.9x
119.2x
2. Growth & Scale
COCH
Revenue Growth (YoY)
-79.3%
+57.1%
Earnings Growth (YoY)
+181.1%
+0.0%
TTM Revenue (USD)
$389,738
$231,000
Market Cap
$18.0M
$51.9M
3. Profitability & Quality
HWH
Gross Margin
N/A
N/A
Operating Margin
-356.2%
-10261.0%
Net Profit Margin
0.0%
0.0%
Return on Equity (ROE)
-87.0%
0.0%
4. Balance Sheet & Cash Flow
COCH
Cash Generation (TTM)
-$955,254
-$21M
Cash Flow Margin
N/A
N/A
Net Cash / Leverage
$1.3M Net Cash
$24M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markup
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Restaurants Operator
Medical Devices Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HWH (3) vs COCH (4)| Institutional Metric | HWH | COCH | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $18.0M | $51.9M | COCH | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | -79.3% | +57.1% | COCH | |
| Operating Margin (TTM) | -356.2% | -10261.0% | HWH | |
| Net Profit Margin | 0.0% | 0.0% | Tie | |
| Return on Equity (ROE) | -87.0% | 0.0% | COCH | |
| 52-Week Range Position | 80% ($1–$3) | 89% ($0–$7) | COCH | |
| Beta / 30D Volatility | 1.02β · 88% Vol | 4.94β · 3352% Vol | HWH | |
| Unified Institutional Score | 37.4 / 100 (SELL) | 35.1 / 100 (SELL) | HWH | |
| Trailing 12M Revenue (USD) | $389,738 | $231,000 | Scale | |
| Gross Profit Margin (TTM) | N/A | N/A | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 42.9x EV/Rev | N/M PEG · 119.2x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$955,254 ($1.3M Net Cash) | -$21M ($24M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
HWH +27.69 pp
3M Horizon
HWH +81.11 pp
6M Horizon
HWH +105.55 pp
1Y Horizon
HWH +79.83 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | HWH Revenue | COCH Revenue | HWH Op. Margin | COCH Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2022 | N/A | $0M | N/A | -3673.4% | COCH |
| FY2023 | $0M | $0M | -91257.8% | -5809.8% | COCH |
| FY2024 | $0M | $0M | -219.4% | -8558.2% | HWH |
| FY2025 | $0M | $0M | -303.4% | -9240.7% | HWH |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HWH
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact HWH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
COCH
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact COCH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HWH Moat Profile
Cyclical / Execution-Driven Positioning
Restaurants Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
COCH Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ HWH vs COCH Key Questions & Quantitative Answers
As of Nov 20, 2026, Envoy Medical, Inc. (COCH) is the stronger overall head-to-head candidate over HWH International Inc. (HWH) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 2–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Balance Sheet & Cash Flow). HWH carries a Unified Composite Score of 37.4/100 (SELL) at $2.68 (N/M Forward P/E, -356.2% operating margin), whereas COCH carries 35.1/100 (SELL) at $6.70 (N/M Forward P/E, -10261.0% operating margin). Composite vs. Pillar Nuance: While HWH currently prints a higher short-term Unified Composite Score (37.4/100 SELL vs. COCH 35.1/100 SELL), COCH captures the overall institutional head-to-head verdict (4–3 matrix metrics and 2–2 across the 6 pillars) due to superior fundamental profitability (-10261.0% vs. -356.2% operating margin) and revenue trajectory (+57.1% vs. -79.3% YoY). Defensive Composite Rating Caution: Although COCH compares more favorably head-to-head, both HWH (37.4/100 SELL) and COCH (35.1/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
COCH leads the Growth & Scale pillar: HWH posts -79.3% YoY revenue growth and +181.1% YoY earnings growth on $389,738 TTM revenue (N/A gross margin, -356.2% operating margin), compared with COCH at +57.1% YoY revenue growth and +0.0% YoY earnings growth on $231,000 TTM revenue (N/A gross margin, -10261.0% operating margin). Across the 4-period historical trajectory (FY2022 to FY2025), HWH cumulative revenue shifted N/A while COCH shifted N/A. In operating R&D and SG&A reinvestment, HWH deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for COCH.
HWH screens cheaper on headline valuation multiples. HWH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 42.9x EV/Revenue (unreported FCF margin), whereas COCH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 119.2x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HWH (-87.0% ROE) versus COCH (0.0% ROE) capital efficiency.
In options market volatility and institutional positioning, HWH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.02β · 88% Vol realized risk). By comparison, COCH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (4.94β · 3352% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
COCH vs HWH · Reverse Pair
HWH vs TWLV
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal